The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic approach in the treatment of nociceptive and neuropathic pain
2022/45/B/NZ7/03101
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Instytut Farmakologii PAN
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 10
Call
OPUS 23 – announced on 2022-03-28
- Amount awarded
- 2 533 291 PLN
- Project start date
- 2023-04-03
- Project end date
- 2027-04-02
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.